Together, these results suggest that STING downregulation is a tumor intrinsic and immune-dependent vulnerability of LKB1-mut lung cancer cells and IAP inhibitors enhance the immune responsiveness of LKB1-mut tumors at least in part through the STING expression restoration. The gene discussed is STING1; the disease is lung cancer.